Gainers
- Aeva Applied sciences AEVA inventory rose 36.6% to $4.25 throughout Thursday’s common session. The corporate’s market cap stands at $229.0 million. As per the press launch, This fall earnings got here out yesterday.
- AuthID AUID shares moved upwards by 29.87% to $7.08. The corporate’s market cap stands at $77.2 million.
- ScanTech AI Programs STAI shares moved upwards by 23.04% to $2.99. The corporate’s market cap stands at $61.9 million.
- Exodus Motion EXOD inventory rose 19.19% to $48.57. The market worth of their excellent shares is at $1.3 billion.
- One Cease Programs OSS shares moved upwards by 14.87% to $2.78. The market worth of their excellent shares is at $58.6 million. As per the press launch, This fall earnings got here out yesterday.
- LeddarTech Holdings LDTC shares moved upwards by 13.25% to $0.64. The market worth of their excellent shares is at $24.0 million.
Losers
- CISO World CISO inventory decreased by 16.6% to $0.52 throughout Thursday’s common session. The corporate’s market cap stands at $7.4 million.
- Alarum Applied sciences ALAR inventory declined by 16.05% to $6.75. The market worth of their excellent shares is at $46.8 million. As per the information, the This fall earnings report got here out right this moment.
- Gorilla Tech Gr GRRR inventory declined by 14.28% to $23.12. The corporate’s market cap stands at $426.9 million.
- MicroAlgo MLGO inventory fell 13.73% to $3.08. The market worth of their excellent shares is at $30.7 million.
- Baijiayun Group RTC inventory fell 13.44% to $0.29. The market worth of their excellent shares is at $7.4 million.
- Locafy LCFY inventory declined by 12.61% to $5.2. The corporate’s market cap stands at $6.6 million.
See Additionally: www.benzinga.com/money/tech-stocks/
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Do not miss a beat on the share market. Get real-time updates on prime inventory movers and buying and selling concepts on Benzinga India Telegram channel.
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.